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ABSTRACT OF THE THESIS
A Web Interface for Quantifying the
Immune Cell Composition of
Tissue Transcriptomes
by
Teia Emiko Kaichi Noel
Master of Science in Bioinformatics
University of California, Los Angeles, 2019
Professor Matteo Pellegrini, Chair
We developed a web tool, SaVanTv2.0, that leverages cell type signatures, or genes highly
expressed in cell types, for characterizing the underlying cell populations of gene expression
data. SaVanTv2.0 offers an accessible web interface, diverse exploratory, inferential, and
predictive analytics, and interpretable visualizations to distinguish cells across disease cat-
egories. We demonstrated SaVanTv2.0’s biomedical applications by (1) suggesting higher
expression of neutrophils and lymphocytes and lower expression of monocytes in early-stage
symptomatic compared with asymptomatic influenza patients, (2) distinguishing higher ex-
pression of B cells, monocytes, and neutrophils, and lower expression of natural killer cells
and plasmacytoid dendritic cells in active compared with latent tuberculosis patients for a
non-invasive diagnosis, and (3) contributing to the discovery of a T cell independent response
that drives lepromatous leprosy. SaVanTv2.0 thereby carries out cell decomposition for the
accessible and interpretable discovery of biomarkers and elucidation of immune responses in
diseased samples.
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1 Introduction
Cell decomposition of gene expression data characterizes cell populations underlying het-
erogenous tissues. Here, we developed a tool called SaVanTv2.0 that utilizes cell type sig-
natures to sift out cell types from gene expression patterns. Cell type signatures are lists of
genes found to be most highly expressed in a cell type population. Cell type quantifications
are performed by computing cell type signature scores, which are the average expression
of all genes listed in the signature corresponding to each cell type. Although a number of
cell decomposition techniques exist that generate and analyze cell type signatures [1, 2],
SaVanTv2.0 increases the accessibility and breadth of its analysis; the tool offers (1) a user-
friendly web interface, (2) diverse analytics including exploratory heatmaps, inferential effect
sizes, and predictive regularized logistic regression, and (3) interpretable visualizations, all
to identify differential cell type expression in two disease categories.
SaVanTv2.0 can not only identify cell type biomarkers for the diagnosis of disease cate-
gories, but also elucidate the immune responses instigated by these diseases. The applica-
tions of SaVanTv2.0 was shown by comparing the cell composition of (1) symptomatic and
asymptomatic influenza patients, (2) active and latent tuberculosis (TB) patients, and (3)
lepromatous leprosy (L-lep) and tuberculoid leprosy (T-lep) patients.
In the first application, the motivation lied in early onset detection of influenza viruses,
H1N1 and H3N2. Early diagnosis of influenza is helpful in avoiding unnecessary treatment
with antibiotics, and diagnostic tests aside from symptom analysis is important to distinguish
influenza from other respiratory infections [3]. Previously, genetic signatures were found to
differentiate asymptomatic and symptomatic H1N1 and H3N2 influenza patients [4]. Fur-
thermore, an exploratory analysis showed that there could be a difference in white blood cell
counts between asymptomatic and symptomatic H3N2 patients that differ from respiratory
infections such as the human rhinovirus and respiratory syncytial virus [5]. SaVanTv2.0 was
utilized to identify differential cell types from gene expression at a higher cellular granularity
1
than previous studies in asymptomatic versus symptomatic influenza patients at a time point
prior to maximal symptom onset.
The analyses provided from SaVanTv2.0 was further applied to address streamlining the
diagnosis of active tuberculosis. According to the World Health Organization, tuberculo-
sis remains a global health problem, and a third of tuberculosis cases are not notified [6].
One shortcoming of current diagnostics include their accessibility; the sputum smear mi-
croscopy test sometimes requires multiple patient visits, reducing patient compliance, while
the Xpert MTB/RIF assay, a nucleic acid amplification test, requires a continuous and stable
power supply not available in health posts of rural areas. Furthermore, the sputum smear
microscopy test lacks specificity. With SaVanTv2.0, cell type markers were identified to
differentiate between active and latent TB, where the latter is asymptomatic and the former
is symptomatic, from patient blood samples, thus providing a non-invasive and accurate test
for TB.
Lastly, the analysis of leprosy patients elucidated immune responses instigated by disease
phenotypes differing by levels of severity. L-lep is the severe form of leprosy, associated with
a B cell response, while T-lep is controlled and characterized by a T cell response [7]. Re-
versal reaction (RR) patients are those who had L-lep and spontaneously upgrade to the cell
mediated immune response of T-lep patients [8]. The prevalence of plasma B cells character-
ized by IGHA immune receptors has previously been identified in L-lep patients [9]. While
the immune components that proliferate across the leprosy spectrum have been previously
defined, little is known about the mechanisms induced by these components. Combining
SaVanTv2.0’s cell decomposition analyses and immune receptor profiling techniques, more
cell types and a detailed view of the immune receptor repertoire that distinguish the lep-
rosy spectrum were explored. Findings here can aid in the development of vaccinations that
mimic the effective immune response, a therapy that does not yet exist for leprosy.
SaVanTv2.0 thereby has the potential to service many clinical applications, grounded in
its extensive analyses and accessible web tool.
2
2 Results
2.1 Signature Score Metric and Visualization
SaVanTv2.0 computes cell signature scores to quantify the expression of cell types given
gene expression data. The input includes our list of immune cell signatures and a matrix
of expression data provided by the user, wherein rows correspond to genes and columns
correspond to patients. In order to compute the signature score of a cell in a patient,
the expression values of all genes in the cell’s signature are averaged. The signature score is
computed across all cell types and all patients, resulting in a matrix, wherein rows correspond
to patients and columns correspond to cell types (Fig. 1a). The SaVanTv2.0 interface allows
the user to upload their expression matrix, after which it outputs a preview of the file. It
then generates the signature score matrix, and presents the output to the user (Fig. 1b,c).
SaVanTv2.0 converts the signature score matrix into an interpretable heatmap. A z-score
is computed for each signature score by subtracting the mean and dividing by the standard
deviation of signature scores for the corresponding cell type across all patients. The matrix of
z-scores is further processed by grouping patients with hierarchical clustering, using average
linkage and the correlation distance metric 1−r
2
, where r is the correlation coefficient resulting
from the Pearson correlation between the z-scores of two patients. Z-scores of cell types are
clustered in the same way, with r being the correlation coefficient between z-scores of two
cell types. Each z-score is associated with a color, where blue indicates a negative z-score,
or signature score that fell below the mean, and red indicates a positive z-score or signature
score that surpassed the mean. The intensity of the color correlates with the magnitude
of the z-score. A heatmap is generated with rows corresponding to cell types, columns
corresponding to patients, and each element indicating the color encoding of the z-score of
each cell type in each patient. Dendrograms along the x and y axes indicate the hierarchical
clustering of patients and cell types, respectively (Fig. 2).
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(a) Signature Score Calculation
(b) Gene Expression Data Upload
(c) Signature Score Matrix output
Figure 1: SaVanTv2.0 Gene Expression Upload and Signature Score Output
(a) SaVanTv2.0 calculates cell type expression scores for every patient by averaging the
expression of all genes in each cell type signature. (b) The web interface asks the user to
upload their gene expression matrix and outputs a preview of the matrix. (c) The web
interface computes and outputs the signature score matrix.
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Figure 2: SaVanTv2.0 Heatmap Output
SaVanTv2.0 outputs a heatmap visualization of the signature score matrix. The x-axis
corresponds to patients and their disease labelings, while the y-axis consists of cell types.
Both axes display dendrograms resulting from hierarchical clustering with average linkage
and correlation distance. Each element of the matrix displays a color indicative of the z-score
of a cell type signature score in a patient, where red indicates the cell type score fell above
the average for that cell type, blue means the cell type score fell below the average, and the
intensity of the color corresponds with the magnitude of each score.
2.2 Effect Size Analysis
In order to quantify differences in cell type expression between patients of two disease
phenotypes, SaVanTv2.0 computes effect sizes and their corresponding p-values between
patient groupings for every cell type. The effect size of a cell type quantifies the magnitude
in the difference in expression of the cell type in two populations. It is calculated with the
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equation
x¯− y¯√
(n1−1)s21+(n2−1)s22
n1+n2−2
where the numerator is the difference in sample means of the signature scores of the cell
type in the two patient groupings, and the denominator is the pooled standard deviation of
the signature scores of the cell type (s1 and s2 defined as the sample standard deviations of
the signature scores in each group, and n1 and n2 the population sizes). Furthermore, the
p-value indicating the probability of observing the difference given the null hypothesis that
no difference exists.
SaVanTv2.0 outputs a bar plot for the effect sizes corresponding to all cell types. Again,
blue indicates a negative effect size and red indicates a positive effect size, and the color
intensity corresponds with the magnitude of the metric. The sample mean of the second
disease category is subtracted from the first disease category in the user’s original uploaded
gene expression matrix and should be interpreted accordingly. Asterisks label effect size that
are associated with a p < 0.05, or significant difference in expression of a cell type between
the two populations (Fig. 3).
2.3 Disease Classification
In order to analyze the expression of immune cell types as potential predictive measures of
different disease phenotypes, SaVanTv2.0 uses the R glmnet package for regularized binomial
logistic regression. The features it uses are the signature score values of all cell types. The
user designates which of the two disease phenotypes is given the response 0 and which is
assigned 1. Furthermore, the user can specify the degree of polynomial feature generation
from a choice of either quadratic or linear logistic regression and a value for α that dictates
the form of regularization. Lastly, the user is asked to choose the number folds of cross
validation.
SaVanTv2.0 responds to these specifications by outputting all non-zero coefficients in the
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Figure 3: SaVanTv2.0 Effect Size Analysis Output
SaVanTv2.0 computes the effect size of each cell type between patients from each disease
category and outputs a bar plot, wherein the y-axis indicates cell types, and the x-axis shows
the effect size values. Blue indicates a negative effect size, while red indicates a positive effect
size, and the intensity of the color corresponds with the magnitude. Asterisks are placed
next to effect sizes that are significantly different between the two diseased groups.
logistic regression model that minimizes the following objective function:
min
(β0,β)∈<p+1
−
[
1
N
N∑
i=1
yi(β0 + x
T
i β)− log(1 + e(β0+x
T
i β))
]
+ λ[(1− α)||β||22/2 + α||β||1]
Specifically, α = 0 designates ridge regularization, α = 1 results in lasso regularization,
and 0 < α < 1 means elastic net. Furthermore, the value for λ used in the objective function
is that corresponding to the logistic regression model that results in the smallest mean
squared error. The analysis outputs a table of non-zero coefficients per cell type signature
score feature. These coefficients are interpreted as how predictive each feature is of one of
the disease phenotypes. Lastly, the analysis outputs a bar plot where red bars correspond
with negative coefficients that favor the 0-labeled disease phenotype and blue bars indicate
positive coefficients that favor the 1-labeled disease phenotype. Again, the intensity of the
color correlates with the magnitude of the coefficients (Fig. 4).
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Figure 4: SaVanTv2.0 Regularized Logistic Regression Analysis Output
SaVanTv2.0 asks the user if they want linear or quadratic regularized logistic regression,
the number of folds for cross validation, and their choice of regularization amongst ridge,
elastic net, and lasso. The interface displays a bar plot of nonzero coefficients, wherein the
y-axis is the cell types, and the x-axis indicates the coefficient values. Blue indicates negative
coefficients, red indicates a positive coefficients, and the intensity of the coloring correlates
with the magnitudes. A table indicating the nonzero coefficients is output below the bar
plot, followed by the minimum misclassification error across all cross validations.
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2.4 Differential Cell Type Analysis of H1N1 and H3N2 Influenza Patients
Time course trends in white blood cell signature scores were comparable to
hematology quantifications in influenza patients
In order to validate SaVanTv2.0’s ability to quantify cell types, cell type signature scores
were compared with hematology white blood cell quantifications over time in H3N2 influenza
patients. SaVanTv2.0 signature scores were generated for selected cell types from whole-
transcriptome microarray data from peripheral blood samples of subjects inoculated with
the H3N2 influenza virus (GEO accession GSE52428). Signature scores for neutrophils,
average lymphocytes (B cells, CD4 T cells, and CD8 T cells), and monocytes were averaged
across symptomatic and asymptomatic patients at a number of time points. In symptomatic
patients, average signature scores for neutrophils and monocytes increased (Fig. 5a,c), while
average scores for lymphocytes decreased by day two after inoculation (Fig. 5b), prior
to symptom onset. On the other hand, asymptomatic patients were characterized by no
clear patterns in neutrophil, average lymphocyte, and monocyte average signature scores
across all four days. Additionally, average signature scores were consistently higher for
average lymphocytes and lower for neutrophils and monocytes in asymptomatic patients
than symptomatic patients for a majority of the time points. These results were comparable
to hematology quantification time course trends for neutrophils, lymphocytes, and monocytes
observed in the same H3N2 patients, verifying SaVanTv2.0’s ability to produce useful cell
type quantifications [5].
Similarly, whole-transcriptome microarray data from peripheral blood samples of patients
inoculated with the H1N1 influenza virus (GEO accession GSE52428) was used to generate
SaVanTv2.0 signature scores for neutrophils, average lymphocytes, and monocytes per pa-
tient. Scores averaged over symptomatic and asymptomatic patients were plotted over time.
Again, symptomatic H1N1 patients were characterized by an increase in average signature
scores for neutrophils and monocytes (Fig 6a,c), and a decrease in average scores for lympho-
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(a) Neutrophils vs. Time (b) Lymphocytes vs. Time
(c) Monocytes vs. Time
Figure 5: Time Course Analysis Distinguishes Expression of White Blood Cells in Symp-
tomatic and Asymptomatic H3N2 Influenza Patients
Time course plots for (a) neutrophil, (b) lymphocyte, and (c) monocyte signature scores
averaged across symptomatic (red) and asymptomatic (blue) H3N2 influenza patients at
various time points in days. Error bars indicate the mean ± standard deviation.
cytes (Fig. 6b) by day two after inoculation. Asymptomatic H1N1 patients showed no clear
pattern in average signature scores for neutrophils, average lymphocytes, and monocytes
across all time points. Average signature scores were largely higher for average lymphocytes,
and lower for neutrophils and monocytes in asymptomatic versus symptomatic individuals.
Similar results in average signature scores between H1N1 and H3N2 patients showed that
white blood cell time course phenomena are generalizable across influenza strains.
SaVanTv2.0 heatmap suggested differential cell expression in symptomatic and
asymptomatic patients 60 hours after inoculation
Because the time-course analysis revealed an established deviation in cell type signa-
ture scores between symptomatic and asymptomatic individuals at around 2-2.5 days after
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(a) Neutrophils vs. Time (b) Lymphocytes vs. Time
(c) Monocytes vs. Time
Figure 6: Time Course Analysis Distinguishes of White Blood Cell Signature Scores in
Symptomatic and Asymptomatic H1N1 Influenza Patients
Time course plots for (a) neutrophil, (b) lymphocyte, and (c) monocyte signature scores
averaged across symptomatic (red) and asymptomatic (blue) H1N1 influenza patients at
various time points in days. Error bars indicate the mean ± standard deviation.
inoculation with virus, a visual differential cell type expression analysis via SaVanTv2.0’s
heatmap feature was conducted on H1N1 and H3N2 patients at 2.5 days after inoculation.
Furthermore, SaVanTv2.0 allowed us to identify differences at a higher cellular granularity
compared with the McClain et al. study.
In the heatmap derived for the H3N2-inoculated patients at 60 hours, the left-hand side of
the x-axis consisted of 7/8 = 87.5% symptomatic patients. Here, monocytes and neutrophils
were generally shown to be highly expressed in symptomatic patients, which is consistent
with the time-course analysis of the signature scores and the white blood cell percentages
in the McClain et al. study. Interestingly, there seemed to be high expression of effector
memory CD4 T cells and naive CD8 T cells in symptomatic patients, a finding that was
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lost in the time-course analyses because lymphocyte signature scores were averaged so as
to make direct comparisons with lymphocyte white blood cell percentages provided in the
McClain et al. study. The lymphocytes that appeared to be lowly expressed in symptomatic
patients included central memory CD8 T cells, naive CD4 T cells, and effector memory CD8
T cells (Fig. 7a).
The right-hand side of the heatmap of H3N2-inoculated patients at 60 hours was com-
prised of 5/7 ≈ 71.4% asymptomatic patients. This region of the heatmap suggested high
expression of central memory CD8 T cells, naive CD4 T cells, and CD8 effector memory
T cells, and low expression of monocytes, effector memory CD4 T cells, and immature
neutrophils, and naive CD8 T cells in asymptomatic patients. Again, while low expres-
sion patterns of monocytes and neutrophils were consistent with findings in the time-course
analyses, there was variation in highly versus lowly expressed lymphocytes (Fig.7a).
As for the heatmap corresponding with the H1N1-inoculated patients at 60 hours, clusters
differentiating symptomatic versus asymptomatic individuals were not as well defined. On
the left-hand side, there was a cluster consisting of 5/9 ≈ 55.6% symptomatic patients.
Here, monocytes, immature neutrophils, neutrophils, central memory CD8 T cells, central
memory CD4 T cells, and immature B cells seemed to be highly expressed. On the other
hand, plasmacytoid dendritic cells, natural killer cells, myeloid dendritic cells, and naive
CD4 T cells seemed to be lowly expressed in symptomatic patients. While high expression
of monocytes and neutrophils in symptomatic patients was consistent with the time course
analyses, high expression of central memory T cells and immature B cells was not previously
apparent. Furthermore, cell types found to be lowly expressed in symptomatic patients
included those beyond the set of white blood cells observed in the time course analyses (Fig.
7b).
The other cluster was comprised of 10/14 ≈ 71.4% asymptomatic patients. Here, mono-
cytes, immature neutrophils, neutrophils, central memory CD8 T cells, and central memory
CD4 T cells appeared to be lowly expressed, while effector memory CD4 T cells, plasma
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B cells, plasmacytoid dendritic cells, myeloid dendritic cells seemed to be highly expressed
in asymptomatic patients. Low expression of monocytes and neutrophils and high expres-
sion of lymphocytes, albeit a variety of them, were findings consistent with the time course
evaluations. However, low expression of central memory T cells, and high expression of
plasmacytoid and myeloid dendritic cells were previously hidden (Fig. 7b).
While there existed discrepancies as well as consistencies in what was concluded from
the heatmap and previous time course studies, there were also consistencies in cell type
expression patterns across patients infected with different influenza strains. For instance,
relatively high expression of monocytes, neutrophils, and CD4 memory T cells was found in
both H1N1 and H3N2 symptomatic patients. This bolsters the idea that general cell type
expression patterns may exist in both influenza strains.
SaVanTv2.0 effect size failed to produce significant differences in type cell
scores in symptomatic vs. asymptomatic patients 60 hours post-inoculation
The effect size analysis provided a more robust, inferential metric for the difference in cell
type expression in symptomatic versus asymptomatic influenza patients. For H3N2 patients,
immature neutrophils, effector memory CD4 T cells, neutrophils, and monocytes resulted in
the highest positive effect sizes, meaning they were more highly expressed in symptomatic
versus asymptomatic patients. On the other hand, memory B cells, naive CD4 T cells,
natural killer cells, and plasmacytoid dendritic cells had the highest negative effect sizes,
meaning they were more highly expressed in asymptomatic versus symptomatic patients.
However, none of the effect sizes were significant (Fig. 8a).
As for H1N1 patients, monocytes, central memory CD4 T cells, and immature neutrophils
were characterized by high positive effect sizes, meaning these cell types were more highly
expressed in symptomatic patients. On the other hand, natural killer cells, effector memory
CD8 cells, and effector memory CD4 T cells had the highest negative effect sizes, meaning
there existed higher expression of these cell types in asymptomatic patients. Again, no
significant results were found. (Fig. 8b).
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(a) H3N2 Influenza Patients
(b) H1N1 Influenza Patients
Figure 7: SaVanTv2.0 Heatmap Analysis Suggests Differences in Cell Type Signature
Scores in Influenza Symptomatic vs. Asymptomatic Patients
SaVanTv2.0 heatmap output for comparison of cell type signatures in peripheral blood of
(a) H3N2 asymptomatic (n = 6) and symptomatic (n = 9) patients, and (b) H1N1 asymp-
tomatic (n = 14) and symptomatic (n = 9) individuals.
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The consistency in the effect size analysis between H1N1 and H3N2 patients, wherein
symptomatic patients seemed to be characteristic of high expression of immature neutrophils,
monocytes and memory CD4 T cells and asymptomatic patients appeared to be characteristic
of high expression of natural killer cells shows that there may be generalizable cell type
biomarkers across the two influenza strains. Furthermore, the while the high expression of
monocytes and neutrophils is consistent with the time course studies, SaVanTv2.0 was able
to differentiate expression of individual lymphocytes, as well as point out non-white blood
cells in symptomatic and asymptomatic patients.
(a) H3N2 Influenza Patients (b) H1N1 Influenza Patients
Figure 8: SaVanTv2.0 Effect Size Analysis Provides Inferential Cell Type Signature Score
Comparison in Influenza Symptomatic vs. Asymptomatic Patients
SaVanTv2.0 effect size bar plot output comparing the difference in average cell type signature
scores in peripheral blood of (a) H3N2 asymptomatic (n = 6) and symptomatic (n = 9)
patients, and (b) H1N1 asymptomatic (n = 14) and symptomatic (n = 9) individuals.
Blue bars correspond with cell types more highly expressed in asymptomatic patients than
symptomatic patients, and red bars correspond with cell types more highly expressed in
symptomatic than asymptomatic patients.
SaVanTv2.0 logistic regression did not output effective models for classification
of symptomatic and asymptomatic patients 60h post-inoculation
The SaVanTv2.0 logistic regression feature failed to produce accurate predictive models
for classifying asymptomatic and symptomatic influenza patients 2.5 days after inoculation.
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For H3N2 patients, the minimum misclassification errors for 5-fold cross validation for ridge,
elastic net, and lasso regularized logistic regression were 40%, 33%, and 40%, respectively.
By extension, this means that the classifier was not able to correctly identify much more
than half of the patients, which is what is expected if it randomly guessed the correct
classifications. For H1N1 patients, the minimum misclassification errors for ridge, elastic net,
and lasso regularized logistic regression were 30%, 35%, and 35%, respectively. Again, the
classifier did not correctly identify substantially more patients than expected if it correctly
guessed classifications at random. The failure to find an accurate classifier for symptomatic
and asymptomatic influenza patients is likely due to the insufficient sample sizes of the two
groupings.
2.5 Discrimination of Cell Types in Latent and Active Tuberculosis
SaVanTv2.0 heatmap feature suggested differential cell type expression pat-
terns in latent vs. active TB patients
In order to discriminate cell type expression patterns in latent and active TB patients,
whole-transcriptome microarray data was gathered from whole blood samples from people
with these disease phenotypes (GEO accession GSE19442). Data was fed into SaVanTv2.0,
which initially generated exploratory results by way of its hierarchical clustering and heatmap
feature. In the region central to the x-axis, where 12/14 ≈ 85.7% of clustered patients were
labeled active, the cell types in the upper-half of the y-axis seemed to be highly expressed
in active patients, whereas the cell types in the lower half of the y-axis seemed to be lowly
expressed in active patients. Those cell types that were deemed highly expressed in active
patients included neutrophils, naive CD8 T cells, monocytes, and immature B cells. On the
other hand, natural killer cells, central memory CD8 T cells, plasmacytoid dendritic cells,
and memory B cells seemed to be lowly expressed in these patients (Fig. 9).
The lefthand side of the heatmap corresponded with a cluster of patients composed of
12/17 ≈ 70.6% latent patients. In this region, there seemed to be opposite trends in lowly vs.
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Figure 9: SaVanTv2.0 Heatmap Analysis Points to Differences in Cell Type Signature
Scores in Active and Latent Tuberculosis Patients
SaVanTv2.0 heatmap output for comparison of cell type signatures in whole blood of active
(n = 22) and latent (n = 29) tuberculosis patients.
highly expressed cell types, where the upper half of the cell types along the y-axis were lowly
expressed and the rest of the cell types were highly expressed. Amongst those cell types that
appeared to be highly expressed in latent patients were natural killer cells, central memory
CD8 T cells, plasmacytoid dendritic cells, memory B cells, and myeloid dendritic cells. In
contrast, neutrophils, naive CD8 T cells, monocytes, immature B cells, and effector memory
CD4 T cells seemed to be lowly expressed in latent patients (Fig. 9).
Similarly, the righthand side corresponded to a cluster comprised of a majority of latent
patients (15/20 ≈ 75%). Here, there existed the trends in the first latent-dominant cluster,
but to a smaller magnitude (Fig. 9).
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SaVanTv2.0 effect size analysis revealed differentially expressed cell types in
latent vs. active TB patients
While the interpretation of the exploratory analysis provided by the heatmap feature of
SaVanTv2.0 were rather arbitrary, the effect size analysis was more grounded in inference,
looking for truth in the population of latent and active TB patients. Here, the trends
suggested by the heatmap analysis were apparent, while pointing to differentially expressed
cell types, or those with significant p-values. While natural killer cells and plasmacytoid
dendritic cells corresponded to the largest and significant effect sizes more highly expressed
in latent than active TB patients, immature B cells, monocytes, immature neutrophils, and
naive CD8 T cells had the largest and significant effect sizes more highly expressed in active
than latent TB patients (Fig. 10).
Figure 10: SaVanTv2.0 Effect Size Analysis Reveals Differential Cell Type Signature Scores
in Active vs. Latent Tuberculosis Patients
SaVanTv2.0 effect size bar plot output comparing the difference in average cell type signature
scores in whole blood of active (n = 22) and latent (n = 29) tuberculosis patients. Blue bars
correspond with cell types more highly expressed in latent patients than active patients, and
red bars correspond with cell types more highly expressed in active than latent patients.
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SaVanTv2.0 regularized logistic regression analysis generated predictive cell
type classifiers of latent and active TB patients
The regularized logistic regression analysis feature of SaVanTv2.0 defined cell types that
are predictive of latent and active tuberculosis phenotypes. The analysis output non-zero
coefficients in the ridge, elastic net, and lasso predictive models, corresponding to the mini-
mum misclassification error across the 5-fold cross validation, that indicate either the latent
or active TB disease phenotype. All three models produced high positive coefficients for
immature B cell scores in favor of active TB patients (17.17 for ridge, 92.08 for elastic net,
and 197.41 for lasso). On the other hand, all three models produced high negative coeffi-
cients for naive B cell scores in favor of latent TB patients (-11.93 for ridge, -32.26 for elastic
net, and -211.45 for lasso). Other important predictive features included B cell memory
scores in favor of latent TB patients under the ridge model with a coefficient of -12.55, and
central memory CD4 T cell scores in favor of active TB patients under the lasso model with
a coefficient of 321.79 (Fig. 11).
The ridge regression model produced the lowest minimum misclassification error across
all 5 cross validations of 16%, meaning it correctly identified 84% of active and latent dis-
ease phenotypes. The elastic net model resulted in a minimum misclassification error of
20%, meaning it was able to correctly classify 80% of the disease phenotypes. Lastly, the
lasso model produced a minimum misclassification error of 25%, or 75% accuracy in disease
phenotype classifications.
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(a) Ridge (b) Elastic Net
(c) Lasso
Figure 11: SaVanTv2.0 Regularized Logistic Regression Analysis Determines Most Predic-
tive Cell Type Scores for Active and Latent Tuberculosis Patients
SaVanTv2.0 bar plots of coefficients corresponding to cell type score features generated from
logistic regression with (a) ridge, (b), elastic net, and (c) lasso regularization for the purpose
of active and latent tuberculosis classification.
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2.6 Cell Type and Immune Receptor Analysis for the Differentiation of T-lep
and L-lep
SaVanTv2.0 heatmap and effect size analyses showed that L-lep has a T cell
independent response
Figure 12: SaVanTv2.0 Heatmap Analysis Points to Differences in Cell Type Signature
Scores in Lepromatous and Tuberculoid Leprosy Patients
SaVanTv2.0 heatmap output for comparison of cell type signatures in skin lesions of lepro-
matous (n = 9) and tuberculoid (n = 6) leprosy patients.
In order to understand the components of the immune response instigated in L-lep pa-
tients compared to T-lep patients, whole-transcriptome RNA-Seq data was collected from
skin lesions of patients with these disease phenotypes. First, the cellular composition of the
immune responses was explored by inputting the gene expression data into SaVanTv2.0, and
analyzing the output of the heatmap analysis. Cell signature scores corresponding to L-lep
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patients clustered on the lefthand and righthand regions of the heatmap. Plasma B cells,
central memory CD4 T cells, naive CD4 T cells, and naive CD8 T cells appeared to be highly
expressed in L-lep patients (Fig. 12).
On the other hand, T-lep patients clustered towards the center of the x-axis. This region
indicated that myeloid dendritic cells, immature B cells, plasmacytoid dendritic cells, natural
killer cells, neutrophils, immature neutrophils, naive B cells, memory B cells, and effector
memory CD8 T cells were highly expressed in T-lep patients compared to L-lep patients
(Fig. 12).
Figure 13: SaVanTv2.0 Effect Size Analysis Determines Differential Cell Type Signature
Scores in Lepromatous Leprosy vs. Tuberculoid Leprosy Patients
SaVanTv2.0 effect size bar plot output comparing the difference in average cell type
signature scores in skin lesions of lepromatous (n = 9) and tuberculoid (n = 6) leprosy
patients. Blue bars correspond with cell types more highly expressed in tuberculoid
patients than lepromatous patients, and red bars correspond with cell types more highly
expressed in lepromatous than tuberculoid patients.
The inferential effect size analysis output by SaVanTv2.0 was also analyzed. This out-
put revealed that signature scores corresponding with plasmacytoid dendritic cells, myeloid
dendritic cells, and effector memory CD8 T cells produced the largest and significant nega-
tive effect sizes, meaning that there is a higher mean expression of these cell types in T-lep
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samples compared with L-lep samples. Meanwhile, the signature scores of B cells resulted in
the largest positive effect sizes, indicating a larger mean expression of this cell type in L-lep
than T-lep patients (Fig. 13).
Analysis of CDR3 immune receptor sequences revealed that L-lep is charac-
terized by a polyclonal IGHA1 response
In order to examine the antibody response corresponding with the prominence of plasma
B cells found to be prominent in L-lep samples, a couple of immune receptor repertoire
analyses were run on the gene expression data. STAR, a general-purpose read alignment
program was sufficient for detecting the expression of antibody constant chains, or isoforms,
defining the mode of attack against the pathogen. However, in order to identify variable
chains, indicating the effectiveness of a response, a novel RNA-Seq analysis tool called ImReP
was used to build the CDR3 amino acid sequences (cite?).
Because the constant region of immune receptors does not originate from complicated
DNA processing, STAR data provided a standard for the number of antibodies, or IGH,
present in the L-lep and T-lep skin samples. The number of reads classified as variable
IGH genes by ImReP and constant IGH genes by STAR were highly Pearson correlated (r
=0.87735). This confirmed the validity of the data produced by ImReP (Fig. 14).
The diversity of the antibody response, defined by the number of variable regions that
emerge when exposed to a pathogen, tells us about how effective a response is. For example,
a polyclonal response lacks specificity when targeting a pathogen, and is thus ineffective. In
order to analyze the diversity of the antibody response in the different types of leprosy, the
number of unique CDR3 sequences per patient was analyzed. Raw counts of unique CDR3
sequences showed that L-lep patients produced the largest count out of all leprosy variants.
L-lep patients had 1065 unique CDR3, while RR patients had 409 and T- lep patients had
213. All these data indicate that L-lep patients have the most diverse CDR3 repertoire (Fig.
15a).
Furthermore, the relationship between the diverse antibody response and the constant
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Figure 14: Validation of ImReP: Read Counts for ImReP Variable IGH Genes Correlate
with STAR Read Counts for Constant IGH Genes
A scatter plot with a solid line showing a Pearson correlation of the number of reads described
as variable IGH genes per sample by ImReP (x-axis) and the number of reads mapped to
constant IGH genes per sample by STAR (y-axis) for all leprosy patients (n=24). Specifically,
the x-axis represents the log of the number of reads per sample output by ImReP that
corresponded to CDR3 that matched > 1 read, normalized by the total number of mapped
reads by STAR. The y-axis represents the read counts per IGH gene normalized by DESeq2
version 1.14.1.
antibody isotype IGHA1 was explored. Across the leprosy spectrum, the association between
the IGHA1 expression, and the number of IGH unique CDR3 showed a strong correlation
(r = 0.90). This indicated that IGHA1 corresponds to a polyclonal immune response in all
types of leprosy (Fig. 15b).
3 Discussion
SaVanTv2.0 provides an interactive and accessible web-interface for the digital differen-
tiation of immune cell type expression patterns in gene expression data from two disease
phenotypes. SaVanTv2.0 leverages 16 immune cell-specific signatures for the quantification
of immune cell type expression, composed of the top 25 most highly expressed genes in
each cell type. The cell type expression metric is computed in a sample by averaging the
expression of all the genes in its corresponding signature.
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(a) (b)
Figure 15: CDR3 Analysis Shows that Lepromatous Leprosy is Characterized by a Poly-
clonal IGHA1 Response
(a) Bar graphs where the x-axis shows the number of the unique complementarity-
determining regions (CDR3) of the IGH variable chain indicated by reads extracted from
lepromatous leprosy (LL, red), reversal reaction (RR, blue) and tuberculoid leprosy (TL,
green) patients. (b) Scatter plot where each dot corresponds to a lepromatous leprosy (red),
reversal reaction (blue) or tuberculoid leprosy (red) patient. The y-axis shows the z-score of
the number of reads that aligned to the IGHA1 isotype, and the x-axis shows the z-score of
the number of IGH unique CDR3. The line represents a positive Pearson correlation.
With the immune cell signatures, SaVanTv2.0 generates a number of visualizations for
easy-to-interpret comparisons of the cell type expression patterns in the user-specified disease
phenotypes. For example, SaVanTv2.0 outputs a heatmap, wherein the coloring of each
element in the heatmap indicates how highly or lowly expressed a cell type is in a sample, and
hierarchical clustering outputs dendograms along the axes, grouping samples and cell types
with similar cell type expression patterns. This provides an exploratory visualization that is
suggestive of cell type expression trends across sample groupings. Additionally, SaVanTv2.0
offers an effect size analysis, where the the difference in mean cell type expression levels in
the two disease phenotypes is output and significant differences are labeled. This analysis
is useful in its inferential basis, pointing out differential cell type expression patterns that
may be revealing of the truth found in the population of the disease phenotype groupings.
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Lastly, SaVanTv2.0 provides regularized logistic regression models meant to classify the two
disease phenotypes. The tool outputs a list of all non-zero coefficients, indicating which cell
type scores are most predictive of one phenotype or the other, summarizes these results in
an interpretable bar plot, and states the minimum misclassification error across the number
of cross validations the user specifies.
Furthermore, SaVanTv2.0 is widely accessible. The application is available on a web
interface, bypassing the programming environments unfamiliar to scientists without bioin-
formatic expertise. Here, analyses and outputs are available at the user’s discretion: the user
uploads an expression matrix indicating the disease phenotypes she/he wishes to compare,
and she/he is free to pick an analysis that best suits his/her research question. The logis-
tic regression analysis is particularly flexible, allowing the user to choose between linear or
polynomial features, a preferred regularization method amongst ridge, elastic net, and lasso,
and the number of cross validations the algorithm should run.
The applications of SaVanTv2.0 were exemplified by applying the tool to three sample
datasets: (1) Time course peripheral blood microarray data from asymptomatic and symp-
tomatic influenza patients, (2) Whole blood microarray data from active and latent TB
patients, and (3) RNA-Seq data from skin biopsies of L-lep and T-lep patients. The findings
of the first dataset showed that time course trends in the signature scores of white blood cells
matched hematology quantifications in the same cohort of symptomatic and asymptomatic
H3N2-inoculated patients. This result alone verified the cell signature scores as reasonable
quantifications of cell types. Furthermore, SaVanTv2.0’s heatmap and effect size analy-
ses pointed to cell type expression patterns differentiating symptomatic from asymptomatic
H3N2 and H1N1 influenza infections about 2.5 days after infection, a time point prior to
maximal symptom onset. This finding bolsters the potential of SaVanTv2.0 to elucidate cell
type biomarkers generalizable across multiple early-stage influenza infections, and use these
biomarkers as a diagnostic for early-onset influenza diagnosis.
In the context of tuberculosis, SaVanTv2.0 was able to find cell type expression patterns
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predictive of active tuberculosis to a high degree of accuracy from non-invasive blood samples.
This is an important accomplishment because TB remains a worldwide health problem, with
approximately a third of cases going undiagnosed. Current diagnostic tests are suboptimal
in their sensitivity, energy cost, and/or ability to foster patient compliance. SaVanTv2.0
presents results that may streamline the diagnosis of active TB, requiring a single non-
invasive blood sample.
In the analysis of leprosy patients, SaVanTv2.0 was paired with immune repertoire analy-
ses of gene expression data to better understand the polyclonal and thus non-antigen specific
B cell independent immune response found to characterize L-lep. This likely explains the
severe symptoms of L-lep patients compared with T-lep patients. Leprosy still lacks a vac-
cination, and determining a more holistic view of the immune pathways present in different
forms of leprosy is important for understanding how vaccines could work to produce an
effective immune response.
In future versions of SaVanTv2.0, we hope extend its clinical application by compar-
ing multiple disease phenotypes in one analysis, and broaden the analysis of underlying
biomarkers or cell pathways by incorporating cell signatures beyond the set of immune cells.
Nonetheless, the current version of SaVanT has to potential to not only streamline the
diagnosis of disease phenotypes by identifying cell type biomarkers, but also to provide in-
formation about the immune responses instigated by certain disease phenotypes, useful for
suggesting new therapies.
4 Methods
4.1 Immune Cell Signature Generation
Cell type signatures were collected from the Primary Cell Atlas [10], a public database
of microarray data for a number of purified cell types. A list of 16 immune cell types were
curated, and the 25 most highly expressed genes per cell type were selected for each signature.
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4.2 Web Interface Development
All SaVanTv2.0 analyses were implemented in R. In order to extend these analyses to a
web interface, the package R Shiny was used. R Shiny provides functions that provide two
aspects of the interface: the design of the interface itself and the analyses of the inputs that
the user provides.
4.3 Example Datasets and Processing
SaVanTv2.0 was tested on datasets corresponding to three disease analyses: (1) influenza,
(2) tuberculosis, and (3) leprosy. The datasets used for the influenza analysis came from
public whole-transcriptome microarray time course data from peripheral blood samples of
H1N1-infected and H3N2-infected humans (GEO accession GSE52428). Data was parti-
tioned into an H1N1-infected subset and H3N2-infected subset, and each subset was further
categorized into symptomatic and asymptomatic individuals. There were 9 symptomatic
and 14 asymptomatic H1N1-inoculated patients, and 9 symptomatic and 6 asymptomatic
H3N2-inoculated patients. All data was log2 normalized and input into SaVanTv2.0.
The second dataset was acquired from a publicly available whole-transcriptome microar-
ray data of South African whole blood samples with latent (n = 29) or active (n = 22) TB
(GEO accession GSE19442). This dataset was log2 normalized and fed into SaVanTv2.0.
The last dataset is composed of whole-transcriptome RNA-Seq data from skin lesion
biopsies of 9 L-lep, 6 T-lep, and 9 reversal reaction patients. The human ribosomal RNA was
depleted and cDNA sequencing libraries were prepared through random hexamer priming.
Libraries were sequenced single-end using a HiSeq2000 (Illumina, San Diego), producing 50-
base pair reads. For each file, Trim Galore! was employed, which uses Cutadapt for trimming
low quality base calls and adapter sequences, and FastQC for reporting statistics about the
quality of the reads. The trimmed reads were then input into STAR version 2.4.2 [11],
which aligned the reads to a composite human (hg19) and Mycobacterium leprae (Br4923)
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genome. This step resulted in both read alignments and unmapped reads. Mapped exonic
gene counts were calculated through HTSeq version 0.6.1 using GENCODE annotation file
(version 24lift37), and exonic counts were summed per gene. Human genes with less than
five reads in at least one patient group (L-lep, RR and T-lep) were filtered out. Normalized
gene counts were then calculated using DESeq2 version 1.14.1. DESeq scaling factors were
based on human reads only.
The normalized dataset was initially input into SaVanTv2.0 for cell type expression
analyses. Additional analysis of leprosy RNA-Seq data to analyze the immune receptors
across the clinical spectrum. The Read Origin Protocol (ROP) [12] was used in order to
characterize the reads unable to be mapped by STAR [11]. These reads fall into a number of
categories, including low quality and low complexity RNA, rRNA, lost human RNA, circular
RNA, RNA resulting from gene fusions, and RNA derived from microbial organisms. Here,
the low quality, low complexity, rRNA and lost human read identification protocols were
selected. ROP by default runs two subsequent steps that classify repeat sequences and non-
co-linear reads, but these steps were skipped. ROP was used purely for filtering out reads
unlikely to be classified as immune receptors.
While RNA-seq reads occasionally map to genes encoding both variable and constant
regions of T and B cell receptors, many variable reads remain too complex to map. This is
because they span the junctions of gene segments, a region called CDR3. ImReP (cite), a
tool used for classifying CDR3 amino acid sequences from unmapped reads, was used in order
to obtain a detailed characterization of the immune receptor repertoire. After low quality,
low complexity, rRNA and lost human reads were identified and filtered, the remaining reads
were fed into ImReP. ImReP output the list of reads and their corresponding CDR3 amino
acid sequence, as well as V, D and J gene segments. Additional steps were taken in order
to filter out potentially spurious data output by ImReP. Per patient, and for each BCR
subunit, defined by the immunoglobulin heavy (IGH), immunoglobulin kappa (IGK) and
immunoglobulin lambda (IGL) chains, a list of unique CDR3 sequences was compiled, along
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with the number of reads that mapped to each sequence. Unique CDR3 are defined as CDR3
that correspond to reads that aligned only once. All CDR3 sequences corresponding to one
read was filtered out. The number of unique CDR3 sequences per leprosy type were counted
and compared across individuals. Additionally, The abundance, or percentage of total reads,
was compared to the number of unique CDR3 sequences in L-lep and T-lep patients using the
Alakazam abundance curve. IGHA, previously found to have a larger presence in L-lep than
T-lep was our focus. In order to determine whether this receptor corresponded with a diverse
immune response or not, a Pearson correlation was computed between the number of reads
mapping to each of these chains and the number of unique CDR3 sequences corresponding
with IGH in each patient.
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